Belief in Treatment as Prevention and its Relationship to HIV Status and Behavioural Risk

How have attitudes towards Treatment as Prevention (TasP) among gay, bisexual and other men who have sex with men changed over time?

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025